Little Green Pharma Ltd (ASX:LGP)

ALERT: Price-sensitive ASX Announcement for LGP

Current share price for LGP : $0.072 -0.015 (-17.24%)⁺

Announcement

Implementation of Merger between LGP and Cannatrek

Release

1 Jun 2026 9:32AM

Price at Release

$0.087

Full Release

Summary

Little Green Pharma Ltd (LGP) successfully implemented its merger with Cannatrek Ltd, acquiring 100% of Cannatrek's issued share capital. The merger, approved by Cannatrek shareholders and the Federal Court of Australia, creates a leading international medicinal cannabis group with integrated operations across cultivation, manufacturing, distribution, clinics, and digital health platforms. Cannatrek, a prominent player in the Australian medicinal cannabis market, brings significant scale and diverse capabilities. The merger is expected to deliver strategic synergies and support LGP's European expansion plans. Key leadership changes include Paul Long continuing as Group CEO and Brent Dennison as Independent Non-Executive Chair, with new board members joining and several retirements announced.

Key Points

LGP acquires 100% of Cannatrek's issued share capital.
Merger approved by Cannatrek shareholders and Federal Court of Australia.
LGP Cannatrek Group to have operations in cultivation, manufacturing, distribution, clinics, and export.
Cannatrek is a leading medicinal cannabis business in Australia.
Merger strategy includes European growth and expansion.
Paul Long continues as Group CEO.
Brent Dennison became Independent Non-Executive Chair.
Ms. Fleta Solomon and others retire from the Board.
New board members include Brent Dennison, Thomas Huppert, and Seth Yakatan.
Post-merger, Cannatrek shareholders hold ~60.5% of LGP's issued capital.

IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.